approved EB-2 (NIW)

Pediatric Resident

Immunology · Bosnia and Herzegovina · 2022-04-22

Processing Time
591 days
Decision Date
2022-04-22
Location
District of Columbia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize immunological and molecular biology techniques to develop inclusive and effective T-cell therapies. Her work focuses on improving outcomes for patients suffering from high-risk solid tumor cancer, hematologic malignancies, and post-transplant viral infections, specifically treating complications from hematopoietic stem cell transplantations.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research supports the creation of treatments for cancer and viral patients who respond poorly to conventional therapeutics, which is of great importance to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

The petitioner's expertise is demonstrated by her involvement in 6 clinical trials, a patent application, and a strong citation record of 260 citations.

3 Waiver Benefit Met

The petitioner's work is supported by major government health institutions, indicating that her continued research provides a benefit that outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 2 peer-reviewed journal articles, 9 peer-reviewed abstracts, and 260 citations. Evidence included participation in 6 clinical trials, a provisional patent application, and support from 4 expert letters confirming the national significance of her research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Grants
Original Contributions
Clinical Deployment
Government Alignment

Similar Cases

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.

Scientist

Biotechnology · Australia

WeGreened EB-2 (NIW) approved
Texas 55 days 2022-03-25
The petitioner proposes to enhance cell-based therapies in preclinical and clinical stages by developing high-throughput technologies to assess and identify immune cells with a high degree of accuracy. This work focuses on advancing cancer therapeutics by elucidating the role of extracellular vesicles (EVs) in cancer metastasis.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 467 days 2025-02-25
The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
New Jersey 180 days 2025-09-03
The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 591 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist